SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Harbour BioMed announced today that it has licensed its patented H2L2 transgenic mouse platform for generating fully human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results